Judge Dismisses Off-Label and Kickback Allegations Against Bristol-Myers Squibb, But BMS Must Face Whistleblower Retaliation Suit Read more
CMS: Open Payments Data Submission and Attestation Period Open until Midnight April 3, 2015 Read more
BioChemics, Inc. Pays the SEC $17.9 Million For Allegedly Misrepresenting FDA Review and Drug Trial Status To Investors Read more
District Court Denies Amgen’s Motion for Preliminary Injunction to Prevent Marketing of Sandoz’s Biosimilar Zarxio Read more